Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Clasificación en acciones #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Precio por acción
$0.089
Última sincronización: 2026-08-17
Capitalización bursátil
$15.36M
Cambio (1 día)
50.59%
Cambio (1 año)
111.85%
País
US
Comercio Inhibitor Therapeutics, Inc. (INTI)

Categoría

Precio INTI con Capital del mercado a B
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
INTI
$0.089
Capitalización de mercado de Inhibitor Therapeutics, Inc.(INTI)
Capitalización bursátil: $15.36M
A fecha de August 2026, Inhibitor Therapeutics, Inc. tiene una capitalización de mercado de $15.36M. Esto convierte a Inhibitor Therapeutics, Inc. en la 30838th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Inhibitor Therapeutics, Inc. desde 2003 hasta 2026
INTI en comparación con los más populares 5 títulos stocks
Precio por INTI Activo B Capital del mercado en B Resultados
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$30,749.66 $15.36M
$5.307T +34,550,085.07%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$26,369.80 $15.36M
$4.551T +29,628,891.27%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$24,072.99 $15.36M
$4.154T +27,048,208.47%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$20,794.30 $15.36M
$3.589T +23,364,277.97%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$16,206.69 $15.36M
$2.797T +18,209,663.87%